All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
Initiation of Voluntary Recalls: Draft Guidance for Industry and FDA Staff
By Mark Land, AAHP President Product recalls are an important tool that manufacturers and the U.S. Food and Drug Administration (FDA) use to minimize...
Overview: Membership Meeting 2019
The membership of AAHP came together on March 8 for the association’s semiannual Membership Meeting. Taking place during Natural Products Expo West in Anaheim, Calif.,...
Reduce Risk with Product Substantiation
Susan J. Hewling When bringing products to market, it is essential to build a platform that allows all information generated...
The Only Constant in Retail is Change
By Ray Petrick, Vice President of Sales, Boiron USA The retail landscape is changing—and dramatically. During the past 10 years, retail disruption has become the...
Why Pharmacovigilance Matters
By Mark Land, AAHP President Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or...
The Homeopathic Pharmacopeia of India
By Eric L. Foxman A quick look at its structure and contents, as well as the potential for adulteration and misbranding in the U.S. market....
Advancing Global Collaborations: News from the World Integrated Medicine Forum
By Eric L. Foxman, Secretary AAHP We are very familiar with the regulatory status and acceptance of homeopathic medicines in the United States. We also...
